Specific inhibition of Type II inosine monophosphate dehydrogenase activity of Tmolt4 T cell human leukaemia cells by 3-methoxy and di-benzohydroxamic acids, maleic hydrazide and malonic acids

Journal of Pharmacy and Pharmacology

Volumn 53, Issue 5, 2001, Pages 749-755

  Hall, I H ^a   Barnes, B J ^a   Ward, E S ^a   Wheaton, J R ^a   Izydore, R A ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOHYDROXAMIC ACID; INOSINATE DEHYDROGENASE; MALEIC HYDRAZIDE; MALONIC ACID; MYCOPHENOLIC ACID; RIBAVIRIN; URIDINE PHOSPHATE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; KINETICS; LEUKEMIA CELL LINE; PURINE SYNTHESIS; T CELL LEUKEMIA;

ANTINEOPLASTIC AGENTS; CELL DIVISION; HUMANS; HYDROXAMIC ACIDS; IMP DEHYDROGENASE; INOSINE MONOPHOSPHATE; LEUKEMIA, T-CELL; MALEIC HYDRAZIDE; MALONATES; TUMOR CELLS, CULTURED;

EID: 0035016481     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357011775884     Document Type: Article

References (17)

1. Barnes, B. J., Eakin, A. E., Hall, I. H. (2000) Selective inhibition of human molt-4 leukaemia Type II inosine-5′monophosphate dehydrogenase by 1,5-diazabicyclo(3.1.0)hexane-2,4-diones. Biochemistry 39: 13641-13650
2. Becker, J. H., Lohr, G. W. (1979) Inosine-5′-phosphate dehydrogenase activity in normal and leukemic blood cells. Klin. Wochenschr. 57: 1109-1115
3. 1210 cells. J. Biol. Chem. 256: 1695-1704
4. Dayton, J. S., Lindsten, T., Thompson, C. B., Mitchell, B. S. (1994) Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase. J. Immunol. 152: 984-991
5. Geran, R. J., Greenburg, N. H., MacDonald, M. M., Schumacher, A. M., Abbott, B. J. (1972) Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemo. Rep. 3: 9-11
6. Hager, P. W., Collart, F. R., Huberman, E., Mitchell, B. S. (1995) Recombinant human inosine monophosphate dehydrogenase type I and II protein. Biochem. Pharmacol. 49: 1323-1329
7. Hall, I. H., Taylor, K., Izydore, R. A., Daniel D. L. (1998) Effects of benzohydroxamic acids on L1210 lymphoid leukaemia cell nucleic acid metabolism. Pharmazie 53: 794-799
8. Hall, I. H., Izydore, R. A., Warren, A. E., Barnes, C. R. (1999) Cytotoxicity and mode of action of aliphatic dicarboxylic acids in L1210 lymphoid leukaemia cells. Anticancer Res. 19: 205-212
9. 4 T cell IMP dehydrogenase. Res. Comm. Pharm. Tox. In press
10. 4 leukemic Type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones (1), 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3.5-azetidinediones (2), 3,5-isoxazolidinediones (3), and 4,4-disubstituted-3,5-pyrazolidinediones. Arch. der Pharm. In press
11. 4 leukemic Type II IMP dehydrogenase by 2,3-dihydrophthalazine-1,4-diones, indazolones, 3-imino-1-oxoisodolines, homophthalimides, napthalidimides, diphenamides, and 6,7-dihydro-5H-dibenz(c,e)azepines. Arch. Pharm. Pharm. Med. Chem. In press
12. Lowry, O. H., Rosebrough, J., Farr, A. L., Randall, R. J. (1951) Protein measurements with folin phenol reagent. J Biol. Chem. 193: 265-275
13. Nagai, M. Y., Natsumeda, Y., Konno, Y., Hoffman, R., Irino, S., Weber, G. (1991) Selective up-regulation of Type II inosine-5′-monophosphate dehydrogenase messenger RNA expression in human leukaemia. Cancer Res. 51: 3886-3890
14. Nagai, M. Y., Natsumeda, Y., Weber, G. (1992) Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukaemia cells. Cancer Res. 52: 258-261
15. Natsumeda, Y., Carr, S. Y. (1993) Human Type I and II IMP dehydrogenase as drug targets. Ann. NY Acad. Sci. 696: 88-93
16. Senda, M., Natsumeda, Y. (1994) Tissue-differential expression of two distinct genes for human IMP dehydrogenase. Life Sci. 54: 1917-1926
17. Wang, W., Papov, V. V., Minakawa, N., Matsuda, A., Biemann, K., Hedstrom. L. (1996) Inactivation of inosine-5′-phosphate dehydrogenase by the antiviral agent 5-ethynyl-1-β-D-ribofuranoyl-imidazole-4-carboxamide-5′- monophosphate. Biochemistry 35: 95-101